Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Estrógeno tópico vaginal y dehiscencia de la cúpula vaginal en pacientes con histerectomía total laparoscópica

Topical vaginal estrogen and vaginal vault dehiscence in patients rather than a laparoscopic total hysterectomy.

Ginecol Obstet Mex. 2019 febrero;87(2):93-99.

https://doi.org/10.24245/gom.v87i2.2418

Fred Morgan-Ortiz, Dalia Gabriela Sosa-Atondo, Fred Valentín Morgan-Ruiz, Juan Manuel Soto-Pineda, Josefina Báez-Barraza, Felipe de Jesús Peraza-Garay

Hospital Civil de Culiacán, Centro de Investigación y Docencia en Ciencias de la Salud, Universidad Autónoma de Sinaloa.


Corrrespondencia:

Fred Morgan Ortiz
fmorganortiz@hotmail.com

Debe citarse como:

Morgan-Ortiz F, Sosa-Atondo DG, Morgan-Ruiz FV, Soto-Pineda JM, Báez-Barraza J, Peraza-Garay FJ. Estrógeno tópico vaginal y dehiscencia de la cúpula vaginal en pacientes con histerectomía total laparoscópica.  Ginecol Obstet Mex. 2019 febrero;87(2):93-99. https://doi.org/10.24245/gom.v87i2.2418

Resumen

OBJETIVO: Comparar la frecuencia de dehiscencia de la cúpula vaginal en pacientes tratadas con y sin estrógenos equinos conjugados por vía vaginal antes de la histerectomía total laparoscópica.

MATERIALES Y MÉTODOS: Ensayo clínico controlado, comparativo, ciego simple, efectuado en pacientes atendidas entre enero de 2013 y agosto de 2016 en el Hospital Civil de Culiacán con indicación de histerectomía total laparoscópica por enfermedad benigna. Criterios de inclusión: haber recibido durante tres semanas previas al procedimiento estrógenos equinos conjugados por vía vaginal (grupo de estudio) o crema lubricante vaginal como placebo (grupo control). Criterios de exclusión: pacientes con diabetes mellitus tratadas con esteroides y antecedente de un evento tromboembólico reciente. Se evaluó la frecuencia de dehiscencia de la cúpula vaginal a los 7 y 30 días posteriores a la cirugía. Se utilizó la prueba t de Student para comparar medias y la χ2 para la comparación de proporciones, con cálculo de riesgo relativo para evaluar el riesgo de dehiscencia de la cúpula vaginal.

RESULTADOS: Se estudiaron 236 pacientes con edad promedio, en ambos grupos, de 47.1 y 47.7 años, respectivamente (p > .05). Los antecedentes ginecoobstétricos y las indicaciones para histerectomía fueron similares en ambos grupos (p = .340). La incidencia total de dehiscencia de la cúpula vaginal fue de 4.6% (n = 11/236) con frecuencia de 6.8% (n = 8/118) en las pacientes del grupo tratado con lubricante vaginal y de 2.5% (n = 3/118) en el grupo tratado con estrógenos equinos conjugados por vía vaginal, sin diferencias entre ambos grupos (p = .123; RR=.359; IC95%: .093-1.387).

CONCLUSIONES: El riesgo de dehiscencia de la cúpula vaginal fue similar entre el grupo que recibió lubricante y el de estrógenos tópicos vaginales, pero con una tendencia menor en la frecuencia de dehiscencia de la cúpula vaginal en el grupo tratado con estrógenos tópicos.

PALABRAS CLAVE: Vaginal; estrógenos equinos conjugados; histerectomía total laparoscópica; crema lubricante vaginal; dehiscencia.

Abstract

OBJECTIVE: To compare the frequency of vaginal cuff dehiscence in patients managed with and without conjugated equine estrogens vaginally prior to total laparoscopic hysterectomy (TLH).

MATERIALS AND METHODS: In a single-blind controlled clinical trial, 236 patients with indications for laparoscopic total hysterectomy for benign pathology at the Hospital Civil de Culiacán and who agreed to participate in the study were randomly assigned to receive vaginally conjugated equine estrogens (study group) or vaginal lubricating cream as a placebo (control group) for 3 weeks prior to the procedure. Patients with diabetes mellitus, treated with steroids and history of a recent thromboembolic event were excluded. The frequency of vaginal cuff dehiscence was evaluated at 7 and 30 days after surgery. The student's t-test was used to compare means and the Chi-square test was used to compare proportions, with relative risk (RR) calculation to evaluate the risk of vaginal cuff dehiscence.

RESULTS: We studied 236 patients with average age, in both groups, 47.1 and 47.7 years, respectively (p > .05). The mean age of the patients was similar between the groups (47.1 vs 47.7 years, p>.05). The gynecological-obstetric history and indications for hysterectomy were similar between both groups (p = .340). The incidence of vaginal cuff dehiscence was 2.5% (n = 3) in the group treated with conjugated equine estrogens vaginally and 6.8% (n = 8) in the patients of thse group treated with vaginal lubricant (p= .123; RM= .359; IC95%: .093-1.387).

CONCLUSIONS: The risk of presenting vaginal cuff dehiscence was similar between the group of lubricant and topical vaginal estrogens, but with a lower tendency in the frequency of vaginal cuff dehiscence in the group of topical estrogens.

KEYWORDS: Vaginal; Conjugated equine estrogens; Total laparoscopic hysterectomy; Vaginal lubricating cream; Dehiscence.

    1. Siedhoff MT, et al. Decreased incidence of vaginal cuff dehiscence after laparoscopic closure with bidirectional barbed suture. J Minim Invasive Gynecol 2011;18(2):218-23. https://doi.org/10.1016/j.jmig.2011.01.002
    2. Koh RM, et al. Incidence and characteristics of patients with vaginal cuff dehiscence after robotic procedures. Obstet Gynecol 2009;114(2), Part 1:231-35. DOI: 10.1097/AOG.0b013e3181af36e3
    3. Ulcella S, et al. Vaginal cuff closure after minimally invasive hysterectomy: our experience and systematic review of the literature. Am J Obstet Gynecol 2011;205(2):119e1-119e12. https://doi.org/10.1016/j.ajog.2011.03.024
    4. Hur HC, et al. Incidence and patient characteristics of vaginal cuff dehiscence after different modes of hysterectomies. J Minim Invasive Gynecol 2007;14(3):311-7. https://doi.org/10.1016/j.jmig.2006.11.005
    5. Hur HC, et al. Vaginal cuff dehiscence after different modes of hysterectomy. Obstet Gynecol 2011;118(4):794-801. DOI: 10.1097/AOG.0b013e31822f1c92
    6. Jeung IC, et al. A prospective comparison of vaginal stump suturing techniques during total laparoscopic hysterectomy. Arch Gynecol Obstet 2010;282(6):631-38. https://doi.org/10.1007/s00404-009-1300-0
    7. Hwang JA, et al. Vaginal cuff closure: a comparison between the vaginal route and laparoscopic suture in patients undergoing total laparoscopic hysterectomy. Gynecol Obstet Invest 2011;71(3):163-9. https://doi.org/10.1159/000316052
    8. Morgan-Ortiz F, et al. Comparison between unidirectional barbed and polyglactin 910 suture in vaginal cuff closure in patients undergoing total laparoscopic hysterectomy. Surg Tech Int 2013;23(1):1-6.
    9. Gillian S, et al. Potential Role of Estrogens in Wound Healing. Am J Clin Dermatol 2003;4(11):737-43. https://doi.org/10.2165/00128071-200304110-00002
    10. Ashcroft GS, Dodsworth J, Boxtel E. Estrogen accelerates cutaneous wound healing associated with an increase in TGB-β1 levels. Nat Med 1997;3:1209-15.
    11. Morales DE, et al. Oestrogen promotes angiogenic activity in human umbilical vein endotelial cells in vitro and in a murine model. Circulation 1995;91:755-63. https://doi.org/10.1161/01.CIR.91.3.755
    12. Shanker G, et al. Oestrogen modulates the inducible expression of platelet derived growth factor mRNA by monocytes/macropaghes. Life Sci 1995;56:499-507. https://doi.org/10.1016/0024-3205(94)00479-C
    13. Ashcroft GS, et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol 1999;155:1137-46. https://doi.org/10.1016/S0002-9440(10)65217-0
    14. Sato T, et al. Hormonal regulation of collagenolysis in uterine cervical fibroblast. Biochem J 1991;275:645-50. DOI: 10.1042/bj2750645
    15. Sandberg EM, et al. Total Laparoscopic Hysterectomy Versus Vaginal Hysterectomy: A Systematic Review and Meta-Analysis. J Minim Invasive Gynecol 2017;24(2):206-17. https://doi.org/10.1016/j.jmig.2016.10.020
    16. Belull S, et al. Transvaginal Management of Vaginal Cuff Dehiscence with Bowel Evisceration following Delayed Diagnosis. Case Rep Obstet Gynecol 2017;4985382. https://doi.org/10.1155/2017/4985382
    17. Misirlioglu S, Boza A, Arslan T, Urman B Taskiran C. Unidirectional barbed suture for vaginal cuff closure without backward stitch in total laparoscopic hysterectomy. J Obstet Gynaecol Res 2018. https://doi.org/10.1111/jog.13696
    18. Fuchs Weizman N, et al. Vaginal cuff dehiscence: risk factors and associated morbidities. JSLS 2015;19(2). DOI: 10.4293/JSLS.2013.00351
    19. Kim SM, et al. The use of barbed sutures for vaginal cuff closure during laparoscopic hysterectomy. Arch Gynecol Obstet 2018;297(3):691-7. https://doi.org/10.1007/s00404-017-4637-9
    20. Karacan T, et al. Comparison of barbed unidirectional suture with figure-of-eight standard sutures in vaginal cuff closure in total laparoscopic hysterectomy. J Obstet Gynaecol 2018:1-6. https://doi.org/10.1080/01443615.2017.1416597
    21. Uccella S, et al. Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy. Am J Obstet Gynecol 2018;218(5):500.e1-500.e13. https://doi.org/10.1016/j.ajog.2018.01.029
    22. Aydogmus H, et al. Cuff closure by vaginal route in TLH: Case Series and review of literature. J Clin Diagn Res 2017;11(3). DOI: 10.7860/JCDR/2017/25056.9447
    23. Shen Z, et al. Estradiol regulation of nucleotidases in female reproductive tract epithelial cells and fibroblasts. PLoS One 2013;8(7). DOI: 10.1371/journal.pone.0069854

Comentarios